Abstract
It is essential, in order to minimize expensive drug failures, to determine potential toxicity problems as early as possible. In view of the large libraries of compounds now being handled by combinatorial chemistry and high-throughput screening, identification of drug toxicity is advisable even before synthesis. Thus, the use of predictive toxicology is called for. A great number of in silico approaches to toxicity prediction have been described in the literature, but one of the most ambitious goals of QSAR applications to toxicology is modeling of chemical carcinogenicity, which has severe consequences on the quality of life and has led to enormous investments in time, financial resources, and animal lives necessary to test the chemicals adequately. This review attempts to summarize present knowledge related to the computational prediction of carcinogenicity. Several computational protocols are described, ranging from knowledge-based approaches and statistically-based systems to simple and fast procedures based on only the 2-D graphing of the investigated structures. Comparative tests of the ability of these systems to predict carcinogenicity show that improvement is still needed. The consensus approach is recommended, whereby the results from several prediction systems are pooled.
Keywords: carcinogenesis, qsar, aromatic amines, pahs, expert systems
Current Computer-Aided Drug Design
Title: The Prediction of Carcinogenicity from Molecular Structure
Volume: 1 Issue: 3
Author(s): Aliuska Morales Helguera, Miguel Angel Cabrera Perez, Robert D. Combes and Maykel Perez Gonzalez
Affiliation:
Keywords: carcinogenesis, qsar, aromatic amines, pahs, expert systems
Abstract: It is essential, in order to minimize expensive drug failures, to determine potential toxicity problems as early as possible. In view of the large libraries of compounds now being handled by combinatorial chemistry and high-throughput screening, identification of drug toxicity is advisable even before synthesis. Thus, the use of predictive toxicology is called for. A great number of in silico approaches to toxicity prediction have been described in the literature, but one of the most ambitious goals of QSAR applications to toxicology is modeling of chemical carcinogenicity, which has severe consequences on the quality of life and has led to enormous investments in time, financial resources, and animal lives necessary to test the chemicals adequately. This review attempts to summarize present knowledge related to the computational prediction of carcinogenicity. Several computational protocols are described, ranging from knowledge-based approaches and statistically-based systems to simple and fast procedures based on only the 2-D graphing of the investigated structures. Comparative tests of the ability of these systems to predict carcinogenicity show that improvement is still needed. The consensus approach is recommended, whereby the results from several prediction systems are pooled.
Export Options
About this article
Cite this article as:
Helguera Morales Aliuska, Perez Angel Cabrera Miguel, Combes D. Robert and Gonzalez Perez Maykel, The Prediction of Carcinogenicity from Molecular Structure, Current Computer-Aided Drug Design 2005; 1 (3) . https://dx.doi.org/10.2174/1573409054367655
DOI https://dx.doi.org/10.2174/1573409054367655 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets Cancer Chemoprevention by Dietary Phytochemicals: Promises and Pitfalls
Current Pharmaceutical Biotechnology Process Variables and Design of Experiments in Liposome and Nanoliposome Research
Mini-Reviews in Medicinal Chemistry Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design Biologics for ANCA-Associated Vasculitis
Inflammation & Allergy - Drug Targets (Discontinued) Use of Mesenchymal Stem Cells in Crohn's Disease and Perianal Fistulas: A Narrative Review
Current Stem Cell Research & Therapy Bioactive Chromone Derivatives – Structural Diversity
Current Bioactive Compounds EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Anticancer α-Helical Peptides and Structure / Function Relationships Underpinning Their Interactions with Tumour Cell Membranes
Current Protein & Peptide Science Chemistry of Plant Dyes: Applications and Environmental Implications of Dyeing Processes
Current Environmental Engineering Current and Emerging Strategies in Bladder Cancer
Anti-Cancer Agents in Medicinal Chemistry The Centrosome: A Target for Cancer Therapy
Current Cancer Drug Targets Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Mini-Reviews in Medicinal Chemistry HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Current Gene Therapy Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry Estrogen Regulation of Adipose Tissue Functions: Involvement of Estrogen Receptor Isoforms
Infectious Disorders - Drug Targets Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Imiquimod
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The DNA-Binding and Bioactivity of Rare Earth Metal Complexes
Mini-Reviews in Medicinal Chemistry 7-O-aminoalkyl-2,3-dehydrosilibinins: Synthesis and in vitro Anti-cancer Efficacy
Anti-Cancer Agents in Medicinal Chemistry